
7th Edition of Cardiology World Conference
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 7th Edition of Cardiology World Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
7th Edition of Cardiology World Conference (Cardio 2026)
Date: October 08–10, 2026
Venue: Hilton Tokyo Narita Airport, 456 Kosuge, Narita City, Chiba 286-0127, Tokyo, Japan
Event Type: Hybrid (In-person + Virtual)
Theme: "Cardiology Innovation: Shaping the Future of Heart Health"
About the Conference
The 7th Edition of Cardiology World Conference (Cardio 2026) is a premier global event designed to unite cardiologists, cardiovascular surgeons, researchers, healthcare practitioners, academicians, industry experts, and policymakers. Held in Tokyo, Japan, from October 8–10, 2026, this hybrid conference offers both physical and virtual participation, ensuring accessibility for a worldwide audience.
The conference aims to foster knowledge exchange, collaboration, and innovation in the field of cardiology. Attendees will engage with international experts, explore emerging trends, and discuss transformative practices shaping the future of cardiovascular medicine. The program includes original research presentations, case studies, expert-led sessions, workshops, and dynamic discussions focused on practical applications and professional growth.
Key Highlights
- Hybrid Participation: Join in person at Hilton Tokyo Narita Airport or attend virtually from any location.
- Scientific Sessions: Covering topics such as Geriatric Cardiology, Pediatric Cardiology, Digital Cardiology and AI, Structural Cardiology, and more (see full list below).
- Networking Opportunities: Connect with global experts, researchers, and industry leaders.
- Abstract Submission: First round closes on June 27, 2026.
- Early Bird Registration: Available until June 30, 2026.
Scientific Sessions
- Clinical Case Reports on Cardiology
- Geriatric Cardiology
- Lipidology
- Pediatric Cardiology
- Valvular Heart Disease
- Cardiovascular Imaging
- Cardio-Oncology
- Congenital Heart Diseases
- Metabolic and Systemic Heart Diseases
- Coronary Artery and Vascular Diseases
- Global Cardiovascular Challenges
- Digital Cardiology and AI
- Critical Care Cardiology
- Structural Cardiology
- Nanotechnology and Cardiovascular Medicine
- Personalized Cardiology and Precision Medicine
Target Audience
- Cardiologists
- Cardiovascular Surgeons
- Researchers
- Healthcare Practitioners
- Academicians
- Industry Experts
- Policymakers
Contact Information
Phone: +1 (702) 988-2320
WhatsApp: +1 (640) 666-9566
Email: [email protected]
Important Links
Data sheet
| Event Name | 7th Edition of Cardiology World Conference (Cardio 2026) |
| Event Date | October 08–10, 2026 |
| Event Status | Upcoming |
| Venue | Hilton Tokyo Narita Airport |
| City | Narita City |
| State / Region | Chiba |
| Country | Japan |
| Organizer | Magnus Group (confirmed from official website consent/footer text) |
| Official Event Website | cardiologyworldconference.com |
| Event Type | Hybrid conference (in-person + virtual) |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | Global, supported by hybrid access and international faculty representation |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for volume metrics; organizer website confirms event format, scope, venue, dates, theme, and participant profile, but not attendee count. |
| Main Purpose of Event | Global knowledge exchange, presentation of cardiovascular research, clinical education, networking, collaboration, and visibility for medical, research, and health innovation stakeholders. |
The 7th Edition of Cardiology World Conference is a hybrid international medical conference focused on cardiology, cardiovascular surgery, clinical practice, research, and emerging technologies influencing heart health. The official website positions the event as a three-day forum covering scientific sessions such as pediatric cardiology, geriatric cardiology, lipidology, cardiovascular imaging, cardio-oncology, structural cardiology, digital cardiology and AI, precision medicine, and global cardiovascular challenges.
From a commercial and lead-generation perspective, this event matters because it gathers clinical experts, academic institutions, hospitals, healthcare practitioners, researchers, and policy-oriented participants in one environment. It is most relevant for companies offering medical devices, diagnostics, clinical software, digital health platforms, imaging solutions, AI-enabled cardiology tools, research services, education partnerships, and hospital innovation solutions. As a hybrid event, it also broadens access beyond Japan and strengthens international outreach potential.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Cardiologists and physician specialists | Hospitals, heart institutes, university medical centers | Clinical evaluators, treatment pathway influencers, product adopters | High relevance for medical devices, imaging, diagnostics, monitoring, and digital cardiology tools |
| Cardiovascular surgeons | Surgical hospitals, specialty centers, academic hospitals | Procedure-specific buyers and technical validators | Relevant for surgical devices, structural heart products, implants, and perioperative solutions |
| Researchers and principal investigators | Universities, research institutes, clinical trial groups | Influence technology validation, publications, and collaborative studies | Strong fit for CRO services, lab technologies, data platforms, and research partnerships |
| Healthcare practitioners | Clinics, hospitals, outpatient cardiovascular care providers | Operational users and implementation stakeholders | Useful for workflow solutions, remote monitoring, training, and care management tools |
| Academicians and medical educators | Medical schools, teaching hospitals, professional education bodies | Influence curriculum, research collaboration, and technology awareness | Relevant for simulation, education platforms, CME support, and academic partnerships |
| Industry experts and medtech/commercial leaders | Medical device, diagnostics, pharma, digital health companies | Partnership, licensing, channel, and product commercialization influence | Good for strategic alliances, sponsorships, KOL engagement, and channel development |
| Policymakers and public health stakeholders | Health agencies, policy bodies, public research networks | Framework and adoption influence rather than direct purchase in many cases | Relevant for population health, outcomes research, and public-private collaboration |
| Hospital innovation, IT, and digital health teams | Hospitals, integrated care systems, health tech programs | Evaluate interoperability, AI, analytics, telehealth, and patient monitoring systems | High relevance for software, AI, connected devices, and health data solutions |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Narita City | Venue-local attendees, airport-access travelers, local hospital and academic visitors | Low to medium | Venue location supports easy air access rather than a purely local audience base |
| Chiba Prefecture | Regional clinicians, hospitals, universities, healthcare administrators | Medium | Reasonable regional feeder market for in-person attendance |
| Greater Tokyo area | Major concentration of hospitals, research institutes, universities, medtech and pharma firms | High | Official site markets the event as “Tokyo, Japan,” increasing metro-area relevance |
| Japan national market | Physicians, surgeons, researchers, health institutions, industry stakeholders from across Japan | High | Hybrid format improves domestic participation beyond the venue catchment area |
| Asia-Pacific | Regional cardiology professionals, researchers, and healthcare innovators | Medium to high | Proximity and hybrid participation make APAC a likely international source market |
| Global | International faculty, virtual delegates, research collaborators, industry representatives | Medium | Official website explicitly invites global experts and offers virtual participation from anywhere |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official website positions the conference as a hybrid international event, welcomes global experts and participants, and lists committee/speaker organizations from the United States and United Kingdom. Virtual participation materially extends international reach. |
| National / Regional | Secondary reach description | Japan-based in-person attendance is likely supported by the Tokyo/Narita location and airport accessibility. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Baylor College of Medicine | Academic medical institution | Official website lists Yochai Birnbaum as committee member and speaker | bcm.edu | Professor of Cardiology, Research Director, Cardiovascular Program Director, Innovation Lead | Confirmed Speaker Organization |
| The University of Texas Health Science Center at San Antonio | Academic health science center | Official website lists Robert J. Chilton as committee member and speaker | uthscsa.edu | Chair of Cardiology, Clinical Research Director, Department Administrator, Digital Health Lead | Confirmed Speaker Organization |
| Albany Medical Center | Academic medical center / hospital | Official website lists Yong Xiao Wang as committee member and speaker | amc.edu | Cardiology Department Head, Research Program Manager, Innovation Director, Clinical Operations Lead | Confirmed Speaker Organization |
| HeartbeatsZ Academy | Professional training / education organization | Official website lists Narendra Kumar as committee member and speaker | heartbeatszacademy.com | Founder, Education Director, Training Partnerships Lead, Clinical Program Manager | Confirmed Speaker Organization |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief of Cardiology / Chair of Cardiology | Clinical Leadership | C-Level / VP / Director | High clinical authority and strong influence on technology adoption and institutional partnerships |
| 2 | Cardiologist / Interventional Cardiologist | Clinical Services | Manager / Director / Individual Contributor | Direct end-user and evaluator for devices, software, diagnostics, and treatment innovations |
| 3 | Cardiovascular Surgeon | Surgery | Director / Individual Contributor | Important for structural heart, surgical instrumentation, implants, and perioperative solutions |
| 4 | Research Director / Principal Investigator | Research | Director / VP | Key for studies, validation partnerships, publication impact, and trial collaboration |
| 5 | Clinical Operations Director | Operations | Director | Relevant for deployment, workflow integration, and scaling of new clinical solutions |
| 6 | Hospital Procurement Manager | Procurement / Supply Chain | Manager / Director | Important for formal purchase decisions after clinical validation |
| 7 | Chief Medical Information Officer / Health IT Director | IT / Digital Health | C-Level / Director | Critical for digital cardiology, AI, data integration, telehealth, and cybersecurity governance |
| 8 | Medical Education Director | Education / Academic Affairs | Director / Manager | Useful for training partnerships, conference education support, and clinician upskilling programs |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core attendee base includes hospitals and clinical care institutions | Clinical technology adoption, care delivery tools, monitoring solutions |
| 2 | Medical Devices | Strong fit for cardiology equipment, interventional solutions, imaging, and monitoring | Partnerships, product evaluation, clinician engagement |
| 3 | Pharmaceuticals | Relevant for cardiovascular therapeutics and scientific engagement | KOL outreach, medical affairs collaboration, educational sponsorship |
| 4 | Biotechnology | Supports translational research, biomarkers, precision medicine, and innovation programs | Research partnerships and scientific validation |
| 5 | Information Technology & Services | Digital cardiology and AI are named scientific sessions | Clinical software, interoperability, analytics, telehealth |
| 6 | Computer Software | Relevant to AI, diagnostics software, remote monitoring, workflow tools | Clinical decision support and digital health deployment |
| 7 | Research | Research institutions and investigators are core participants | Trials, studies, publications, research services |
| 8 | Higher Education | Academic faculty and medical schools are represented | Education partnerships, academic collaboration, training |
| 9 | Education Management | Conference includes training, presentations, and professional development value | CME, educational content, simulation, learning programs |
| 10 | Health, Wellness & Fitness | Relevant to preventive cardiology and patient-engagement innovation | Preventive care platforms and population health solutions |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Not confirmed | Official website content provided | No official attendee count found in supplied source |
| Exhibitor count | Not publicly confirmed | Not confirmed | Official website content provided | No exhibitor directory or floor plan identified in supplied source |
| Buyer count | Not publicly confirmed | Not confirmed | Official website content provided | Conference format suggests decision-makers attend, but no quantified buyer breakdown is published |
| Speaker count | At least 4 named in supplied source excerpt | Partially confirmed | Official speaker / committee section in supplied source | The website also says “View All Members,” indicating more may exist, but only four are confirmed in the provided text |
| Sponsor count | Not publicly confirmed | Not confirmed | Official website content provided | No sponsor page or sponsor roster in supplied source |
| Historical attendance | Not verified from supplied source | Historical data unavailable | Past event navigation links shown, but no confirmed attendance figure in provided content | No prior-year official attendance number used |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Digital Cardiology and AI | Clinical decision support, predictive analytics, workflow optimization, remote care | Demonstrations, pilot programs, hospital IT discussions, research collaborations | AI platforms, clinical software, monitoring tools, data integration services |
| Cardiovascular Imaging | Higher diagnostic accuracy and improved imaging workflow | Clinical validation, imaging use-case discussions, procurement planning | Imaging systems, software analysis tools, archiving and reporting platforms |
| Structural Cardiology | Interventional and procedural innovation | Surgeon and specialist engagement, evidence-led adoption conversations | Devices, implants, procedure-support tools, surgical technologies |
| Pediatric and Geriatric Cardiology | Age-specific diagnostics, care pathways, patient management solutions | Department-level targeting and specialty workflow engagement | Diagnostic tools, care management systems, educational content |
| Precision Medicine | Personalized treatment planning and patient stratification | Research alliances, biomarker discussions, trial design partnerships | Genomics-enabled tools, analytics, biotech partnerships |
| Critical Care Cardiology | Rapid monitoring, ICU workflow support, patient stability management | Hospital operations and high-acuity care targeting | Monitoring devices, alarms, analytics, critical-care software |
| Clinical Research and Case Reporting | Publication support, study collaboration, evidence generation | KOL networking, investigator outreach, sponsored studies | CRO support, analytics, data capture, research software |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Strong fit for healthcare, research, medtech, diagnostics, and digital health suppliers serving cardiology stakeholders |
| Decision-maker availability | Medium to High | Clinical leaders and researchers are confirmed attendee types; procurement heads are likely but not explicitly listed in the supplied source |
| Data collection potential | Medium | Good topical alignment, but current-year public attendee/company list visibility is limited in the supplied source |
| Apollo targeting potential | High | Clear industry, title, department, and geography signals exist for healthcare and research targeting |
| Geographic targeting potential | High | Japan, APAC, and global virtual outreach can be segmented cleanly |
| Best outreach approach | Account-based and specialty-led outreach | Lead with cardiology use cases, clinical outcomes, research support, interoperability, and expert education value |
| Overall lead quality | High | Strong event-topic relevance, international expert positioning, and hybrid delivery create good opportunity for B2B healthcare targeting |
| Best use case | Thought leadership outreach, partnership targeting, hospital innovation prospecting, speaker-organization engagement | Useful for highly targeted campaigns rather than broad attendee-list assumptions |
| Limitations / risks | Medium | Publicly confirmed current-year buyer/entity data is limited; this event is suitable for B2B attendee list building only with supplemental manual verification or organizer-approved data sources |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Information Technology & Services; Computer Software; Research; Higher Education; Education Management; Health, Wellness & Fitness | Focus on cardiology-related clinical, research, and digital health accounts |
| Departments | Medical / Clinical; Research; Operations; Information Technology; Procurement; Education; Business Development | Map both end-user and buyer-side stakeholders |
| Seniority | C-Level; VP; Director; Head; Manager; Partner; Professor | Prioritize decision-makers and domain influencers |
| Job titles | Chief of Cardiology, Chair of Cardiology, Cardiologist, Interventional Cardiologist, Cardiovascular Surgeon, Research Director, Principal Investigator, Clinical Operations Director, CMIO, Health IT Director, Procurement Manager, Medical Education Director | Title-level precision for event-aligned personas |
| Geography | Japan; Chiba; Tokyo; Asia-Pacific; United States; United Kingdom | Blend host-market and international faculty-style targeting |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Capture hospitals, universities, research centers, and established medtech firms |
| Keywords | cardiology, cardiovascular, heart institute, interventional cardiology, cardiovascular imaging, digital cardiology, AI, structural heart, clinical research, precision medicine | Tighten account and contact relevance |
| Technologies, if relevant | EHR, remote monitoring, clinical analytics, telehealth, AI diagnostics | Best for digital health or software-led prospecting |
| Revenue range, if relevant | Mid-market to enterprise; customize based on product ACV | Improves fit for complex medtech and enterprise health solutions |
| Company type | Hospitals, university medical centers, research institutes, specialty heart centers, medtech firms, healthcare education organizations | Reflects the mix of clinical, academic, and industry attendees described by the organizer |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Cardiology World Conference 2026 Official Website | Official event website | Event name, dates, hybrid format, Tokyo/Japan positioning, venue name, Narita City address, theme, audience profile, scientific sessions, abstract and registration deadlines, named committee/speaker organizations | High |
| Official Website Consent/Footer Text Referencing Magnus Group | Official organizer reference within site text | Organizer identification as Magnus Group | Medium to High |
| Supplied official website content excerpt | Primary-source text provided by user | Used as the primary source of truth for event details per instruction | High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 7th Edition of Cardiology World Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.